iPlato Healthcare
iPLATO Healthcare is a UK-based health technology company operating the myGP patient engagement platform, serving NHS Payers, GP surgeries, and 2.8m patients through enterprise SaaS subscriptions for primary care, population health, and Hospital at Home workflows.
- Company typePrivate
- Founded1999
- HeadquartersHammersmith, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What iPlato Healthcare does
iPLATO Healthcare (iPLATO Ltd) is a UK-based health technology company, headquartered in Hammersmith and founded in 1999, that develops and operates myGP, a patient engagement platform serving UK primary care and population health. The company operates a single unified technology platform that powers a modular product portfolio organised into three practice areas: Primary Care (the Connect+ bundle comprising Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and the Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital Front Door), and Hospital at Home (Digital Checklist: SACT and GDm-Health for systemic anti-cancer therapy and gestational diabetes remote monitoring respectively). On top of this platform iPLATO packages vertical care-pathway solutions for Respiratory, Cardio, Cancer, Mental Health, and Research (IRN).
The company's customer base is concentrated within the UK NHS: iPLATO reports deployment at over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network, with 2.8m health-conscious patients using the myGP consumer-facing app. The GTM motion combines enterprise field sales targeting NHS Payers, CCGs, and GP practices (initiated through an "Exploration Call" CTA, indicating quote-based, contract-negotiated enterprise pricing) with a direct-to-consumer layer via the myGP app. Revenue is generated primarily through recurring SaaS subscriptions sold to NHS and primary care providers, with the myGP app functioning as an engagement channel into the B2B platform.
iPLATO is part of the Huma Therapeutics group, evidenced by the iPLATO website linking to the Huma Therapeutics Carbon Reduction Plan, co-branded Hospital at Home products, and the December 2024 launch of Huma Intelligence & Selfbook that integrates Huma's capabilities into the iPLATO platform. Leadership comprises Tobias Alpsten as Chief Executive Officer and Namrata Sarmah in a Chief Product / CXO role. The company is privately held (no public ticker disclosed) with disclosed funding of approximately $7.7m across rounds led by SBRI Healthcare (2016, 2023) and Caple BV (2020), and operates UK-based teams in the UK and Czech Republic with 51–100 total employees.
iPlato Healthcare firmographics
Firmographics- Name
- iPlato Healthcare
- Legal name
- iPLATO Ltd
- Website
- https://iplato.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- iPLATO Healthcare is a UK-based health technology company operating the myGP patient engagement platform, serving NHS Payers, GP surgeries, and 2.8m patients through enterprise SaaS subscriptions for primary care, population health, and Hospital at Home workflows.
- Ownership category
- akta.pro rank
iPlato Healthcare industry classification
Industry- Product category
- Healthcare Patient Engagement Software
- NAICS
- Home Health Care Services (621610)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
- akta.pro secondary industries
- Care Navigation, Referral & Digital Front Door Platforms (HLALABAH), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)
Keywords
Where iPlato Healthcare is headquartered
LocationHeadquarters
- HQ city
- Hammersmith
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
iPlato Healthcare business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Enterprise SaaS to NHS and primary care providers: Recurring software contracts sold to NHS Payers, CCGs, and GP surgeries for Connect+, Engagement Hub, Data Science, Digital Front Door, and Hospital-at-Home products. Buyer base is the UK NHS and primary care ecosystem, with >50% of NHS Payers as customers.
- Consumer-side engagement via myGP app: Patient-facing myGP app (2.8m health-conscious patients) acts as an engagement surface for NHS/GP customers and a potential adjacent monetisation channel; primary monetisation is on the B2B side via NHS subscriptions.
Go-to-market motion2 records
iPlato Healthcare product offering
Product offeringCore offering
iPlato Healthcare develops and sells the iPLATO patient engagement platform, used by NHS Payers, CCGs and GP surgeries to communicate with patients, manage primary care workflows, run population health programmes and deliver Hospital at Home remote monitoring. Its flagship products include the Connect+ primary care suite, the myGP consumer app, population health modules (Engagement Hub, Data Science, Digital Front Door) and condition-specific tools such as GDm-Health and the SACT digital checklist.
Product overview
iPlato offers a single underlying technology platform — the iPLATO platform — that powers a portfolio of modular products and solutions organised into three practice areas: Primary Care (built around the Connect+ bundle, with sub-modules Connect, Patient Questionnaires, Selfbook, Toolbar, Triage, and Friends and Family Test), Population Health (Engagement Hub, Data Science, and Digital front door), and Hospital at Home (Digital checklist: SACT and GDm-Health). On top of this platform, iPlato packages vertical solutions for Respiratory, Cardio, Research (IRN), Cancer, and Mental Health, alongside the patient-facing myGP app. Together with innovation partners, the platform transforms fragmented care routes into streamlined digital-first patient pathways used by over 50% of NHS Payers, 2,518 GP surgeries, and a 34m patient network.
Differentiator
Problem solved
Functional benefit
Brands
- myGP: Consumer-facing mobile app branded separately from the iPLATO corporate name; 2.8m health-conscious patients reported as users.
- Connect+
- Engagement Hub
- GDm-Health
Products and services
- iPLATO Platform Core unified technology platform from iPlato Healthcare that underpins primary care patient engagement, population health management and Hospital at Home remote monitoring. Used by NHS Payers, CCGs, GP surgeries and secondary care providers.
- Connect+ Primary care patient engagement suite that combines appointment reminders, patient questionnaires, self-booking, toolbar workflows, online triage and Friends and Family Test collection into a single product for GP surgeries and PCNs.
- Engagement Hub Population Health module that delivers targeted, multi-channel patient engagement campaigns at scale for NHS Payers, CCGs and GP surgeries to manage defined patient cohorts.
- Data Science Population Health analytics product that combines iPlato datasets with NHS data sources to deliver population health insight, risk stratification and outcomes analysis for NHS organisations.
- Digital front door Population Health solution that gives patients a single digital entry point into NHS services via online triage, signposting and self-service pathways.
- GDm-Health Hospital at Home remote monitoring product for gestational diabetes, enabling expectant mothers to record and share blood glucose readings with their clinical team outside of hospital.
- SACT digital checklist Hospital at Home digital checklist product supporting systemic anti-cancer therapy (SACT) workflows for oncology teams and their patients.
- myGP Consumer-facing mobile app used by 2.8 million health-conscious patients to manage appointments, repeat prescriptions, NHS login access and other primary care interactions.
- Respiratory solution Condition-specific digital care pathway for respiratory patients, designed for NHS primary and secondary care teams managing long-term respiratory conditions.
- Cardio solution
Companies that use iPlato Healthcare
Customer profileIdeal customer profiles3 records
iPlato Healthcare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
iPlato Healthcare partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights6 records
iPlato Healthcare competitors and assessment
Company assessmentDirect peers
- accuRx: UK primary care patient communication and messaging platform used by GP surgeries for appointment booking, questionnaires and two-way SMS — directly competing with iPLATO's Connect+ suite in the same NHS primary care buying motion.
- eConsult: NHS online consultation and triage platform for GP practices; now part of the Huma Therapeutics group alongside iPLATO, so directly comparable as a primary care digital front-door and triage peer.
Broad incumbents
- EMIS Group: Major UK provider of clinical software (EMIS Web) to GP practices, with adjacent patient engagement and population health capabilities — overlapping with iPLATO's primary care footprint across thousands of NHS GP surgeries.
- TPP (The Phoenix Partnership): UK primary and secondary care EPR and patient-facing software vendor (SystmOne), serving a large share of NHS GP surgeries — a broad incumbent competitor to iPLATO at the practice-IT layer.
- Huma Therapeutics: Parent group of iPLATO and operator of Huma Workspace for health systems, combining digital-first care pathways, remote monitoring and hospital-at-home capabilities that subsume iPLATO's product set within a broader digital health platform.
- Babylon Health (eMed): UK-originated digital health and GP consultation platform, historically competing with iPLATO-adjacent primary care services through NHS partnerships and direct-to-consumer video consultations.
Emerging players
- Doccla: UK-based virtual ward and remote patient monitoring provider with NHS contracts, directly comparable to iPLATO's Hospital at Home products (GDm-Health, SACT) in delivering care outside hospital settings.
- Sensely: Conversational AI triage and patient engagement platform with NHS deployments, comparable to iPLATO's Triage, Digital Front Door and Selfbook capabilities for routing patients into appropriate services.
Regional players
- Push Doctor: UK digital GP consultation service, overlapping with iPLATO's primary care value proposition around patient access to GPs, though focused on video consultations rather than practice-level engagement tooling.
- Livi (by Kry): European digital GP and patient engagement provider (Kry/Livi) operating in the UK NHS via GP federations, overlapping with iPLATO's primary care patient engagement and access proposition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
iPlato Healthcare social profiles
Digital presenceiPlato Healthcare financial estimates
Financial estimateRevenue estimate
Valuation estimate
iPlato Healthcare leadership team
Management profileNumber of profiles
Profiles2 records
iPlato Healthcare funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iPlato Healthcare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iPlato Healthcare
What does iPlato Healthcare do?
iPlato Healthcare develops and sells the iPLATO patient engagement platform, used by NHS Payers, CCGs and GP surgeries to communicate with patients, manage primary care workflows, run population health programmes and deliver Hospital at Home remote monitoring. Its flagship products include the Connect+ primary care suite, the myGP consumer app, population health modules (Engagement Hub, Data Science, Digital Front Door) and condition-specific tools such as GDm-Health and the SACT digital checklist.
Is iPlato Healthcare a public or private company?
iPlato Healthcare is a private company. It is classified as corporate owned and is currently operating.
When was iPlato Healthcare founded?
iPlato Healthcare was founded in 1999. It employs 51 to 100 people.
Where is iPlato Healthcare based?
iPlato Healthcare is headquartered in Hammersmith, United Kingdom, in the Europe region.
How does iPlato Healthcare make money?
Two revenue lines are on record. Enterprise SaaS to NHS and primary care providers are the primary driver. The others are consumer-side engagement via myGP app.
Who are iPlato Healthcare's main competitors?
Direct peers on record are accuRx and eConsult. Broad incumbents are EMIS Group, TPP (The Phoenix Partnership), Huma Therapeutics and Babylon Health (eMed). Emerging players are Doccla and Sensely. Regional players are Push Doctor and Livi (by Kry).
Does iPlato Healthcare have an API?
No public API is recorded for iPlato Healthcare.
What industry is iPlato Healthcare in?
iPlato Healthcare's product category is Healthcare Patient Engagement Software. Its primary akta.pro industry code is HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated), with a secondary code of HLALABAH, Care Navigation, Referral & Digital Front Door Platforms. Its NAICS code is 621610 and its SIC code is 8090.